Using CRISPR/Cas9-based gene editing, we generated Triple Negative Breast Cancer (TNBC) cell lines where endogenous NCL is fused to an AID tag, to promptly control its cellular levels using the phytohormone auxin with unprecedented specificity and temporal resolution. The gene discussed is AICDA; the disease is triple-negative breast carcinoma.